G. Gallo

发表

Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors.

G. Giannini, F. Zunino, L. Musso, 2012, European journal of medicinal chemistry.

Azetidinones as Zinc‐Binding Groups to Design Selective HDAC8 Inhibitors

Walter Cabri, Sergio Penco, Grazia Gallo, 2009, ChemMedChem.

Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90.

G. Giannini, R. Baruchello, C. Pisano, 2011, Journal of medicinal chemistry.

Derivatives of R‐Aminocarnitine without Ammonium Moiety as Liver Carnitine Palmitoyltransferase I (L‐CPT I) Inhibitors

R. Conti, W. Cabri, T. Brunetti, 2011, ChemMedChem.

Aminocarnitine Ureidic Derivatives as Inhibitors of Carnitine Palmitoyltransferase I

R. Conti, W. Cabri, P. Carminati, 2010, ChemMedChem.

Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.

C. Sette, V. Ruggiero, R. De Santis, 2010, Rheumatology.

Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors.

G. Giannini, F. Zunino, L. Musso, 2012, European journal of medicinal chemistry.

Vorinostat-like molecules as structural, stereochemical, and pharmacological tools.

G. Giannini, A. Larsson, S. Hanessian, 2010, ACS medicinal chemistry letters.

2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.

Giovanni Piersanti, Fabrizio Giorgi, Giorgio Tarzia, 2005, Journal of medicinal chemistry.

Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold.

G. Giannini, S. Dallavalle, L. Vesci, 2014, Bioorganic & medicinal chemistry letters.

Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity.

G. Giannini, A. Larsson, S. Hanessian, 2010, Journal of medicinal chemistry.

Design, synthesis, and in vitro activity of peptidomimetic inhibitors of myeloid differentiation factor 88.

V. Ruggiero, R. De Santis, G. Basile, 2008, Journal of medicinal chemistry.

Synthesis of benzo[1,2-d;3,4-d']diimidazole and 1H-pyrazolo[4,3-b]pyridine as putative A2A receptor antagonists.

G. Tarzia, M. Castorina, G. Piersanti, 2007, Organic & biomolecular chemistry.

Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases.

M. Brindisi, S. Gemma, G. Campiani, 2012, Journal of medicinal chemistry.

Synthesis and biological activity of fluorinated combretastatin analogues.

G. Giannini, C. Pisano, W. Cabri, 2008, Journal of medicinal chemistry.

On the Equivalence Between Different Descriptions of Molecules: Value for Computational Approaches

Alessandro Giuliani, Romualdo Benigni, Fabrizio Giorgi, 1999, J. Chem. Inf. Comput. Sci..

Mutational Analysis Identifies Residues Crucial for Homodimerization of Myeloid Differentiation Factor 88 (MyD88) and for Its Function in Immune Cells*

E. Volpe, R. Furlan, L. Battistini, 2013, The Journal of Biological Chemistry.

Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound

Grazia Gallo, Vito Ruggiero, Paolo Carminati, 2007, Journal of leukocyte biology.

Identification of Critical Residues of the MyD88 Death Domain Involved in the Recruitment of Downstream Kinases*

C. Sette, V. Ruggiero, R. De Santis, 2009, Journal of Biological Chemistry.

Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide

Marco Presta, Simona Tomaselli, Stefania Mitola, 2009, Journal of cellular and molecular medicine.

Induced fit and pharmacophore generation approach applied to A2A adenosine receptor antagonists

M. Parenti, M. Mabilia, E. Fioravanzo, 2006 .

Structural Characterization of PTX3 Disulfide Bond Network and Its Multimeric Status in Cumulus Matrix Organization*

A. Mantovani, A. Morreale, R. De Santis, 2008, Journal of Biological Chemistry.

Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation.

Andrea Carpentieri, Alberto Mantovani, Antonio Bastone, 2006, Biochemistry.

Peptide-mediated Interference of TIR Domain Dimerization in MyD88 Inhibits Interleukin-1-dependent Activation of NF-κB*

C. Sette, V. Ruggiero, P. Carminati, 2005, Journal of Biological Chemistry.

QSAR models for discriminating between mutagenic and nonmutagenic aromatic and heteroaromatic amines

R Benigni, R. Benigni, L. Passerini, 1998, Environmental and molecular mutagenesis.

Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.

C. Sette, V. Ruggiero, R. De Santis, 2010, Rheumatology.